Date:6/13/2010

ons held to a non-Muslim belief system, military victories were seen as a victory authorized by Allah for the advancement of Islam.

Beginning with the Battle of Badr in 624 A.D., victories of war were regarded as "proof" of divine support. This conviction deepened during Islam's first millennium (600 A.D. to 1600 A.D.) as it spread across the Middle East, North Africa and as far west as Spain. In the past several decades, Islam has interpreted financial success as evidence of Allah's blessings on Islamic advances. This belief is one of the reasons that even so-called moderate Muslims, as embarrassed as they were by Khomeini's excesses during the Iranian revolution, would not totally disown him. The economic success of Iran under his leadership was "proof" to most in the Islamic world that Khomeini enjoyed the "pleasure of Allah."

The second basic Islamic belief to contend with is that oil is regarded as a material gift from Allah so that Muslims (and Islam as a religion) might achieve world superiority. J.B. Kelly, the author of "Arabia, the Gulf and the West," wrote:

"The Arabs see the oil weapon as a gift sent by God to redress the balance between Christendom and Islam ... and to fulfill the destiny which God in His infinite wisdom has ordained for those to whom He has chosen to reveal the one true faith."

Oil in the 21st century is tantamount to the sword of the seventh century. It is a means of exerting the greatest possible force on non-Muslim adversaries:

Economic success is proof of God's favor. Success results in Islamic superiority '/>"/>

Source: PRWeb Copyright©2010 Vocus, Inc. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors
2. Michael Sitaras of SavATree Earns ISA Certified Arborist Designation
3. Michael J. Fox Foundation Offers High-Quality LRRK2 Antibodies for PD Therapeutic Development
4. Delcath Systems Names Michael D. Dellario as Vice President, Global Marketing
5. Michael Langley, DVM, MBA, RAC Joins the Anson Group as a Regulatory Consultant
6. Oxford BioTherapeutics Appoints Michael Moore as Chairman
7. The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinsons Disease Treatments
8. Double Helix Consulting Enhances its Strategic Product Commercialization Services with Appointment of Michael Rizzo as Vice President
9. Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research
10. Clinical Therapeutics Announces the Addition of Michael G. Spigarelli, MD, PhD, as Editor for a Refocused Pediatric, Adolescent, & Maternal Therapeutics Section
11. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations